相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AT7519 against lung cancer via the IL6/STAT3 signaling pathway
Feng Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Acetylshikonin exerts anti-tumor effects on non-small cell lung cancer through dual inhibition of STAT3 and EGFR
Yemeng Tang et al.
PHYTOMEDICINE (2022)
Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice
Hanjing Sheng et al.
FRONTIERS IN PHARMACOLOGY (2022)
Nintedanib in Progressive Pulmonary Fibrosis A Systematic Review and Meta-Analysis
Marya Ghazipura et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)
Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway
Lehe Yang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Active Components from Traditional Herbal Medicine for the Potential Therapeutics of Idiopathic Pulmonary Fibrosis: A Systemic Review
Ebuka-Olisaemeka Nwafor et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2021)
The role of natural products in the prevention and treatment of pulmonary fibrosis: a review
Liqun Wang et al.
FOOD & FUNCTION (2021)
Gracillin inhibits apoptosis and inflammation induced by lipopolysaccharide (LPS) to alleviate cardiac injury in mice via improving miR-29a
Yin-xue Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities
Peter M George et al.
Lancet Respiratory Medicine (2020)
Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway
Lingyuan Xu et al.
MOLECULAR CARCINOGENESIS (2019)
Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways
Yuting Zhang et al.
PHARMACOLOGICAL RESEARCH (2019)
The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective
Tai Rao et al.
PHARMACOLOGICAL RESEARCH (2019)
What have we learned from basic science studies on idiopathic pulmonary fibrosis?
Toyoshi Yanagihara et al.
EUROPEAN RESPIRATORY REVIEW (2019)
The therapy of idiopathic pulmonary fibrosis: what is next?
Vivien Somogyi et al.
EUROPEAN RESPIRATORY REVIEW (2019)
STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts
David W. Waters et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Quillaja Saponin Characteristics and Functional Properties
Corina L. Reichert et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 10 (2019)
Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants
Dante J. Marciani
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
The tyrosine phosphatase SHP2 controls TGF beta-induced STAT3 signaling to regulate fibroblast activation and fibrosis
Ariella Zehender et al.
NATURE COMMUNICATIONS (2018)
Anti-Atopic Properties of Gracillin Isolated from Dioscorea quinqueloba on 2,4-Dinitrochlorobenzene-Induced Skin Lesions in Mice
Jonghwan Jegal et al.
NUTRIENTS (2018)
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Javier Milara et al.
RESPIRATORY RESEARCH (2018)
Tissue remodelling in pulmonary fibrosis
Lars Knudsen et al.
CELL AND TISSUE RESEARCH (2017)
Idiopathic pulmonary fibrosis
Luca Richeldi et al.
LANCET (2017)
STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation
Mesias Pedroza et al.
FASEB JOURNAL (2016)
Quantitative determination of gracillin by HPLC-MS/MS after oral administration and its application to a pharmacokinetic study
Xinxin Zhang et al.
STEROIDS (2016)
Nintedanib and Pirfenidone New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
STAT3-Mediated Signaling Dysregulates Lung Fibroblast-Myofibroblast Activation and Differentiation in UIP/IPF
Dmitri V. Pechkovsky et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
STAT3 in tissue fibrosis: Is there a role in the lung?
Darryl Knight et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
Investigational approaches to therapies for idiopathic pulmonary fibrosis
Richard H. Gomer et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta 3
Kjetil Ask et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Pierre-Jean Wipff et al.
JOURNAL OF CELL BIOLOGY (2007)
Saponins: Properties, applications and processing
Ozlem Guclu-Ustundag et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2007)
Anti-obesity effect of Dioscorea nipponica Makino with lipase-inhibitory activity in rodents
CS Kwon et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2003)
分享论文
